54092-0064 Agrylin - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

54092-0064

Brand Name:

Agrylin

Generic Name:

Anagrelide

Dosage Form Name:

Capsule

Administration Route:

Oral

Substances:

Packages:

Code: 54092-0064-01

Description:

Effective Date: March 14, 1997

Discontinued: March 31, 2008

SEER*Rx Category:

Ancillary Therapy

Major Class:

Platelet-Reducing Agent

Minor Class:

PDE-3 Inhibitor

Orphan Drug Designation:

Status:

No Longer Used